Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

Buyout by Pfizer...???

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Storage33 Member Profile
 
Followed By 3
Posts 148
Boards Moderated 0
Alias Born 11/08/12
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/21/2014 4:19:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/13/2014 4:28:15 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2014 4:52:28 PM
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting "Business Wire" - 11/6/2014 9:44:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/5/2014 7:41:08 AM
ARIAD Reports Third Quarter 2014 Financial Results and Development Progress "Business Wire" - 11/5/2014 7:35:00 AM
ARIAD to Present at the Stifel 2014 Healthcare Conference "Business Wire" - 11/4/2014 7:35:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/24/2014 4:06:48 PM
ARIAD annuncia l'adozione di un'opinione finale per Iclusig da parte del Comitato europeo per i medicinali per uso umano "Business Wire" - 10/24/2014 10:55:00 AM
ARIAD annonce l'adoption de l'avis définitif sur l’Iclusig par le Comité des médicaments à usage humain en Europe "Business Wire" - 10/24/2014 8:48:00 AM
ARIAD meldet Bestätigung der positiven abschließenden Stellungnahme zu Iclusig durch den Ausschuss für Humanarzneimittel i... "Business Wire" - 10/24/2014 8:23:00 AM
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe "Business Wire" - 10/24/2014 7:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/17/2014 4:23:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/16/2014 4:26:18 PM
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results "Business Wire" - 10/15/2014 7:35:00 AM
ARIAD rende nota la raccomandazione per Iclusig da parte del Comitato di valutazione dei rischi per la farmacovigilanza dell'... "Business Wire" - 10/10/2014 3:43:00 PM
Ariad annonce les recommandations du comité pour l’évaluation des risques en matière de pharmacovigilance de l’Agence ... "Business Wire" - 10/10/2014 10:12:00 AM
ARIAD erhält befürwortende Stellungnahme für Iclusig vom Beratenden Ausschuss für Risikobewertung im Bereich der Pharmako... "Business Wire" - 10/10/2014 7:49:00 AM
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency "Business Wire" - 10/10/2014 7:44:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/10/2014 6:00:32 AM
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology "Business Wire" - 10/6/2014 7:35:00 AM
AP26113 d’ARIAD désigné par la FDA traitement révolutionnaire contre le cancer bronchique non à petites cellules ALK+ r... "Business Wire" - 10/3/2014 12:24:00 PM
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib "Business Wire" - 10/2/2014 7:35:00 AM
ARIAD présente de nouveaux résultats de son étude clinique sur l'AP26113 chez des patients atteints d'un cancer du poumon ... "Business Wire" - 9/30/2014 10:18:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/29/2014 4:05:48 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist